Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elizabeth A. Woolf is active.

Publication


Featured researches published by Elizabeth A. Woolf.


Cell | 1996

Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice

Hong Chen; Olga Charlat; Louis A. Tartaglia; Elizabeth A. Woolf; Xun Weng; Stephen J Ellis; Nathan D Lakey; Janice A. Culpepper; Karen J More; Roger E. Breitbart; Geoffrey M. Duyk; Robert I. Tepper; Jay P. Morgenstern

OB-R is a high affinity receptor for leptin, an important circulating signal for the regulation of body weight. We identified an alternatively spliced transcript that encodes a form of mouse OB-R with a long intracellular domain. db/db mice also produce this alternatively spliced transcript, but with a 106 nt insertion that prematurely terminates the intracellular domain. We further identified G --> T point mutation in the genomic OB-R sequence in db/db mice. This mutation generates a donor splice site that converts the 106 nt region to a novel exon retained in the OB-R transcript. We predict that the long intracellular domain form of OB-R is crucial for initiating intracellular signal transduction, and as a corollary, the inability to produce this form of OB-R leads to the severe obese phenotype found in db/db mice.


Nature | 1997

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

Yang Pan; Clare Lloyd; Hong Zhou; Sylvia Dolich; Jim Deeds; Jose-Angel Gonzalo; Jim Vath; Mike Gosselin; Jingya Ma; Barry J. Dussault; Elizabeth A. Woolf; Geoff Alperin; Janice A. Culpepper; Jose Carlos Gutierrez-Ramos; David P. Gearing

Chemokines are small secreted proteins that stimulate the directional migration of leukocytes and mediate inflammation. During screening of a murine choroid plexus complementary DNA library, we identified a new chemokine, designated neurotactin. Unlike other chemokines, neurotactin has a unique cysteine pattern, Cys-X-X-X-Cys, and is predicted to be a type 1 membrane protein. Full-length recombinant neurotactin is localized on the surface of transfected 293 cells. Recombinant neurotactin containing the chemokine domain is chemotactic for neutrophils both in vitro and in vivo. Neurotactin messenger RNA is predominantly expressed in normal murine brain and its protein expression in activated brain microglia is upregulated in mice with experimental autoimmune encephalomyelitis, as well as in mice treated with lipopolysaccharide. Distinct from all other chemokine genes, the neurotactin gene is localized to human chromosome 16q. Consequently we propose that neurotactin represents a new δ-chemokine family and that it may play a role in brain inflammation processes.


Diabetes | 1997

Cloning and Characterization of an Uncoupling Protein Homolog: A Potential Molecular Mediator of Human Thermogenesis

Ruth E. Gimeno; Marlene Dembski; Xun Weng; Nanhua Deng; Andrew W. Shyjan; Carlos J. Gimeno; Francois Iris; Stephen J Ellis; Elizabeth A. Woolf; Louis A. Tartaglia

We have identified a novel cDNA encoding a protein highly homologous to the mammalian brown fat uncoupling protein (UCP). Unlike the known UCP, which is expressed specifically in brown adipose tissue, the UCP homolog (UCPH) mRNA is expressed in a variety of tissues, with predominant expression in human white adipose tissue and skeletal muscle. In the white adipose tissue of ob/ob and db/db mice, the UCPH transcript is induced approximately fivefold relative to lean littermate controls. Expression of murine UCPH in yeast results in growth inhibition under conditions that require aerobic respiration, but does not affect growth under anaerobic conditions. Furthermore, UCPH expression in yeast causes a decrease in the mitochondrial membrane potential, as judged by staining with the potential-sensitive dye DiOC6. These observations suggest that UCPH, like UCP, uncouples oxidative phosphorylation. The possibility that the UCPH protein is an important mediator of human thermogenesis is discussed.


Cell | 1996

Identification and Characterization of the Mouse Obesity Gene tubby: A Member of a Novel Gene Family

Patrick W. Kleyn; Wei Fan; Steve G Kovats; John Lee; Jacqueline C Pulido; Ye Wu; Lucy R Berkemeier; Don J Misumi; Lisa M. Holmgren; Olga Charlat; Elizabeth A. Woolf; Olga Tayber; Thomas Brody; Pei Shu; Fiona Hawkins; Brenda Kennedy; Linda Baldini; Chris Ebeling; Geoffrey D Alperin; Jim Deeds; Nathan D Lakey; Janice A. Culpepper; Hong Chen; M.Alexandra Glücksmann-Kuis; George A. Carlson; Geoffrey M. Duyk; Karen J. Moore

The mutated gene responsible for the tubby obesity phenotype has been identified by positional cloning. A single base change within a splice donor site results in the incorrect retention of a single intron in the mature tub mRNA transcript. The consequence of this mutation is the substitution of the carboxy-terminal 44 amino acids with 24 intron-encoded amino acids. The normal transcript appears to be abundantly expressed in the hypothalamus, a region of the brain involved in body weight regulation. Variation in the relative abundance of alternative splice products is observed between inbred mouse strains and appears to correlate with an intron length polymorphism. This allele of tub is a candidate for a previously reported diet-induced obesity quantitative trait locus on mouse chromosome 7.


Nature | 2001

Twisted gastrulation can function as a BMP antagonist

Chenbei Chang; Douglas A. Holtzman; Samantha Chau; Troy Chickering; Elizabeth A. Woolf; Lisa M. Holmgren; Jana Bodorova; David P. Gearing; William E. Holmes; Ali H. Brivanlou

Bone morphogenetic proteins (BMPs), including the fly homologue Decapentaplegic (DPP), are important regulators of early vertebrate and invertebrate dorsal–ventral development. An evolutionarily conserved BMP regulatory mechanism operates from fly to fish, frog and mouse to control the dorsal–ventral axis determination. Several secreted factors, including the BMP antagonist chordin/Short gastrulation (SOG), modulate the activity of BMPs. In Drosophila, Twisted gastrulation (TSG) is also involved in dorsal–ventral patterning, yet the mechanism of its function is unclear. Here we report the characterization of the vertebrate Tsg homologues. We show that Tsg can block BMP function in Xenopus embryonic explants and inhibits several ventral markers in whole-frog embryos. Tsg binds directly to BMPs and forms a ternary complex with chordin and BMPs. Coexpression of Tsg with chordin leads to a more efficient inhibition of the BMP activity in ectodermal explants. Unlike other known BMP antagonists, however, Tsg also reduces several anterior markers at late developmental stages. Our data suggest that Tsg can function as a BMP inhibitor in Xenopus; furthermore, Tsg may have additional functions during frog embryogenesis.


Nature | 1999

The mahogany protein is a receptor involved in suppression of obesity

Deborah L. Nagle; Sonja H. McGrail; James Vitale; Elizabeth A. Woolf; Barry J. Dussault; Lisa DiRocco; Lisa Holmgren; Jill Montagno; Peer Bork; Dennis Huszar; Victoria Fairchild-Huntress; Pei Ge; John Keilty; Chris Ebeling; Linda Baldini; Julie Gilchrist; Paul L. Burn; George A. Carlson; Karen J. Moore

Genetic studies have shown that mutations within the mahogany locus suppress the pleiotropic phenotypes, including obesity, of the agouti-lethal-yellow mutant,. Here we identify the mahogany gene and its product; this study, to our knowledge, represents the first positional cloning of a suppressor gene in the mouse. Expression of the mahogany gene is broad; however, in situ hybridization analysis emphasizes the importance of its expression in the ventromedial hypothalamic nucleus, a region that is intimately involved in the regulation of body weight and feeding. We present new genetic studies that indicate that the mahogany locus does not suppress the obese phenotype of the melanocortin-4-receptor null allele or those of the monogenic obese models (Lepdb, tub and Cpefat). However, mahogany can suppress diet-induced obesity, the mechanism of which is likely to have implications for therapeutic intervention in common human obesity. The amino-acid sequence of the mahogany protein suggests that it is a large, single-transmembrane-domain receptor-like molecule, with a short cytoplasmic tail containing a site that is conserved between Caenorhabditis elegans and mammals. We propose two potential, alternative modes of action for mahogany: one draws parallels with the mechanism of action of low-affinity proteoglycan receptors such as fibroblast growth factor and transforming growth factor-β, and the other suggests that mahogany itself is a signalling receptor.


Molecular and Cellular Biology | 1997

Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus.

Samantha J. Busfield; Donna A. Michnick; Troy Chickering; Tracy L. Revett; Jingya Ma; Elizabeth A. Woolf; Christopher A. Comrack; Barry J. Dussault; Jessica Woolf; Andrew D. J. Goodearl; David P. Gearing

Members of the epidermal growth factor family of receptors have long been implicated in the pathogenesis of various tumors, and more recently, apparent roles in the developing heart and nervous system have been described. Numerous ligands that activate these receptors have been isolated. We report here on the cloning and initial characterization of a second ligand for the erbB family of receptors. This factor, which we have termed Don-1 (divergent of neuregulin 1), has structural similarity with the neuregulins. We have isolated four splice variants, two each from human and mouse, and have shown that they are capable of inducing tyrosine phosphorylation of erbB3, erbB4, and erbB2. In contrast to those of neuregulin, high levels of expression of Don-1 are restricted to the cerebellum and dentate gyrus in the adult brain and to fetal tissues.


Circulation | 1998

Human Prostaglandin Transporter Gene (hPGT) is Regulated by Fluid Mechanical Stimuli in Cultured Endothelial Cells and Expressed in Vascular Endothelium in Vivo

James N. Topper; Jiexing Cai; George Stavrakis; Keith R. Anderson; Elizabeth A. Woolf; Barbara A. Sampson; Frederick J. Schoen; Dean Falb; Michael A. Gimbrone

BACKGROUND biomechanical forces generated by blood flow within the cardiovascular system have been proposed as important modulators of regional endothelial phenotype and function. This process is thought to involve the regulation of vascular gene expression by physiological fluid mechanical stimuli such as fluid shear stresses. METHODS AND RESULTS We demonstrate sustained upregulation of a recently identified gene encoding a human prostaglandin transporter (hPGT) in cultured human vascular endothelium exposed to a physiological fluid mechanical stimulus in vitro. This biomechanical induction is selective in that steady laminar shear stress is sufficient to upregulate the hPGT gene at the level of transcriptional activation, whereas a comparable level of turbulent shear stress (a nonphysiological stimulus) is not. Various biochemical stimuli, such as bacterial endotoxin and the inflammatory cytokines recombinant human interleukin 1beta cytokines (rhIL-1beta) and tumor necrosis factor-alpha (TNF-alpha), did not significantly induce hPGT. Using a specific antiserum to hPGT, we demonstrate endothelial expression within the arterial vasculature and the microcirculation of highly vascularized tissues such as the heart. CONCLUSIONS Our results identify hPGT as an inducible gene in vascular endothelium and suggest that biomechanical stimuli generated by blood flow in vivo may be important determinants of hPGT expression. Furthermore, this demonstration of regulated endothelial expression of hPGT implicates this molecule in the regional metabolism of prostanoids within the cardiovascular system.


Nature Genetics | 1996

Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome.

Deborah L. Nagle; Mohammad A. Karim; Elizabeth A. Woolf; Lisa Holmgren; Peer Bork; Donald J. Misumi; Sonja H. McGrail; Barry J. Dussault; Charles M. Perou; Raymond E. Boissy; Geoffrey M. Duyk; Richard A. Spritz; Karen J. Moore


Archive | 1995

Polycystic kidney disease: the complete structure of the PKD1 gene and its protein

Gluecksmann-Kuis; O. Tayber; Elizabeth A. Woolf; L. Bougueleret; N.H. Deng; G.D. Alperin; F. Iris; F. Hawkins; C. Munro; N. Lakey; G. Duyk; Michael C. Schneider; Lin Geng; F. Zhang; Zhihui Zhao; S. Torosian; Jing Zhou; Stephen T. Reeders; Peer Bork; M. Pohlschmidt; C. Löhning; B. Kraus; U. Nowicka; A.L.S. Leung; A.M. Frischauf

Collaboration


Dive into the Elizabeth A. Woolf's collaboration.

Top Co-Authors

Avatar

Karen J. Moore

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Deborah L. Nagle

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

David P. Gearing

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Geoffrey M. Duyk

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barry J. Dussault

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Lisa Holmgren

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Andrew W. Shyjan

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Barry J. Dussault

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Jim Deeds

Millennium Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge